This webinar will explore genetic counseling practices across Latin America through the experiences of two US-trained genetic counselors currently practicing abroad. Speakers will highlight key differences in healthcare systems, access to genetic testing, and clinical workflows, with a focus on challenges and barriers faced by patients outside the United States. The session will also address important considerations for US-based genetic counselors working with Spanish-speaking patients who have cross-border care needs. Attendees will gain practical insights to support more effective communication, care coordination, and culturally informed practice.

Presented by:

NSGC Spanish Development SIG
Gabriela Valverde de Morales, MD
Sonia Margarit, MS, CGC

Learning Objectives:

1. Compare genetic counseling practices across the United States and Latin America, including differences in healthcare systems, testing access, and clinical approaches.
2. Identify key challenges and barriers affecting non-US patients’ access to genetic counseling and testing in Latin America, including system-level, logistical, and resource-related limitations.
3. Apply practical strategies to improve communication, care coordination, and decision-making in cross-border genetic counseling contexts.
4. Recognize opportunities for collaboration and resource-sharing to better support continuity of care for patients and families navigating genetic services across countries.

This webinar will provide an extensive review of hereditary cancer syndromes that confer risk for gastric cancer and other gastric neoplasia. This review will include discussion of genetic testing strategies, current cancer risk estimates, and management of these syndromes from a patient-centric perspective. This webinar will also include a review of non-genetic risk factors and prevention strategies.

Presenters:

NSGC Cancer SIG
Sonia Kupfer, MD
Emma Keel, MS, CGC

Learning Objectives:

1. Define cancer risks associated with hereditary gastric cancer syndromes.
2. Review risk factors and general prevention for gastric cancer.
3. Examine the paradigm shift in the management of Hereditary Diffuse Gastric Cancer patients.
4. Apply new cancer risk estimates and emerging management guidelines to real world cases.

The cystic fibrosis (CF) genetic testing and counseling landscape is rapidly evolving. Transformative CFTR modulator therapies have improved length and quality of life for people with CF, while advanced screening detects CFTR variants that confer a wide and variable phenotypic spectrum, including variants associated with low or reduced penetrance. In this webinar, we will explore common clinical scenarios that result from CFTR screening and testing modalities and offer strategies to promote a nuanced approach to genetic counseling about CFTR variants in the context of conflicting classifications.

Presented by:

NSGC Cystic Fibrosis and CFTR Spectrum SIG
Elinor Langfelder-Schwind, MS, CGC
Emily Calamaro, MGC, CGC
Charlotte Close, MS, CGC
Angel Wooden, MS, CGC

Learning Objectives:

1. Apply reproductive genetic counseling principles to support family-building for individuals with cystic fibrosis in the era of highly effective CFTR modulator therapies.
2. Compare approaches to preconception/prenatal and newborn screening for cystic fibrosis with respect to potential diagnostic outcomes and associated management recommendations
3. Evaluate clinical and genetic factors associated with cystic fibrosis and CFTR-related conditions and their implications for patient monitoring and counseling
4. Synthesize CFTR variant interpretation resources to inform nuanced genetic counseling about unexpected CFTR findings

Genetic Counselors CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, The Evolving Complexity of CFTR Testing and Counseling: A Case-Based Approach. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

Inherited cardiomyopathies are common conditions with estimated prevalence of 1 in 250. Inherited Arrhythmia conditions are rare with estimated prevalence of ~ 1 in 1000. Inclusion of these conditions in the ACMG secondary findings (SF) list was intended to identify individuals at increased risk that could benefit from early detection and treatment. However, these conditions have reduced penetrance and SFs are quite frequent. The risk assessment is not one-size fits all. What is the current data on the pathogenicity of variants detected incidentally? What is the best plan of care in the absence of expert consensus? This session is designed to inform the learner of where we started and where we are now in terms of personalized risk assessment and management.

Presented by:

NSGC Cardiogenetics SIG
Erin Miller, MS, CGC
Sarah Jurgensmeyer Langas, MS, CGC
Laura Zahavich, MSc, CGC

Learning Objectives: 

1. Apply clinical phenotype and family history to guide surveillance strategies for individuals with secondary findings in cardiac disease genes.
2. Identify key molecular, clinical, and family history indicators to guide genetic counseling for patients with secondary findings in genes associated with cardiomyopathy risks.
3. Understand and anticipate implications of secondary findings in inherited arrhythmia genes

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, From Sequence to Surveillance: Making Sense of Secondary Findings in Inherited Arrhythmia and Cardiomyopathy Genes. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

This webinar will begin with background information on preimplantation genetic testing for aneuploidies (PGT-A) and mosaicism, including differences in lab reporting, historical viewpoints about mosaicism and transfer policies (and how that has evolved over time), and a quick summary of current literature on outcomes. The webinar will continue with how non-euploid embryo transfers are managed in a prenatal clinic, what testing (if any) patients are pursuing prenatally and/or postnatally, what the prenatal clinic is finding regarding outcomes and general trends, and cases examples.

Presented by:

NSGC Assisted Reproductive Technologies/Infertility SIG
Emma Moores, MGC, CGC
Jennifer Kussmann, MS, CGC

Learning Objectives:

1. Review the background on PGT-A testing with non-euploid results
2. Describe the historical viewpoints and current embryo transfer policies
3. Explain prenatal testing and screening options
4. Identify case examples to highlight the challenges in pregnancies with atypical embryos

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, The Mosaic Journey: From Transfer to Term. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

This all-inclusive package offers access to the full set of 24 webinars from NSGC’s 2026 Webinar Series, complete with CEUs. Please note that webinars will be added to this package as they are released.

To purchase the 2026 NSGC Webinar Series Full Package, click the blue "Register Now" button next to the package title. Do not register for the individual components included in the package.

Genetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to 2.4 CEUs or 24 Category 1 contact hours for the 2026 NSGC Webinar Series Full Package. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

This is a focused package covering plenary, educational breakout, and on-demand sessions from the NSGC 44th Annual Conference.

To purchase the NSGC 44th Annual Conference General Sessions Package, click the blue "Register Now" button next to the package title. Do not register for the individual components included in the package.

Genetic Counselor CEUs:

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to 4.45 CEUs or 44.5 Category 1 contact hours for the activity, NSGC 44th Annual Conference General Sessions Package. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

The Audrey Heimler Special Projects Award (AHSPA) provides an annual award of $10,000 to one or more genetic counselors for a project that focuses on the future of the genetic counseling profession and/or the provision of genetic services. Join this session to learn additional information about the award, and to hear project updates from a past award winner.

Presented by:

Monisha Sebastin, MS, CGC

Learning Objectives:

1. Identify current global challenges in accessing clinical genetics services
2. Assess the potential strategies by which a global directory could improve direct connection amongst providers and access to genetics services globally

Genetic Counselor CEUs:

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .05 CEUs or 0.5 Category 1 contact hours for the activity, Audrey Heimler Special Projects Award Presentation. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion:

1. View recording
2. Pass quiz
3. Complete evaluation

Program Overview

Please Note: You are not required to complete all modules of the JoGC CEU Program to earn CEUs and you may earn partial credit for the program. You may choose to complete some or all modules. You will only be awarded CEUs for those modules which you pass and complete in full, including the module quiz and evaluation. Please review the CEU credit section below for additional information on available contact hours and certificates.

Continuing Education Unit (CEU) Credits

The Journal of Genetic Counseling CEU Program is approved for 12.0 Contact Hours or 1.2 Category 1 CEU. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification. Individuals must be certified at the time of participation in the activity in order to count towards recertification. 

Register by November 30, 2026 to participate. Program materials must be completed by December 11, 2026 to earn CEUs. CEU certificates will be issued via the NSGC CEU Portal no later than December 18, 2026. Early certificates are not available. 

Access to the Journal of Genetic Counseling (JoGC) is required to participate in the 2026 Journal of Genetic Counseling CEU Program. NSGC members receive complimentary access to the Journal of Genetic Counseling. Please note that non-members are required to purchase access to the Journal of Genetic Counseling separately if they do not already have access to this publication to participate in this program.

This course is designed to help genetic counselors build a practical understanding of postmortem genetic testing (PMGT) and its role in clinical care, death investigation, and family risk assessment. Learners will examine when PMGT should be considered, how testing is integrated into clinical and medicolegal workflows, and how sample availability, consent, laboratory testing, billing, documentation, ethical issues, and psychosocial considerations can affect the process. Through expert perspectives and case-based content, the course emphasizes interdisciplinary collaboration and the genetic counselor’s role in supporting families, coordinating PMGT, and improving access to this area of testing.  

Presented by:

1. Rebecca McClellan, MGC, LCGC
2. Margaret Drohen, MS
3. Emma Schopp, ScM, CGC
4. Leslie KW Cyprych, MS, MPH, CGC
5. Alison Krywanczyk, MD
6. Susan F. Ely, MD, MPHTM
7. Lisa Dellefave-Castillo, MS, CGC
8. Heather MacLeod, MS, CGC
9. Abigail Yesso, MS, CGC
10. Layne Wells-Copeland, MGC, CGC
11. Erin M. Miller, MS, CGC

Learning Objectives:

1. Describe the clinical utility of PMGT and identify scenarios in which PMGT may be appropriate for a deceased individual and their surviving biological relatives.
2. Assess postmortem sample availability and suitability for genetic testing, including collection methods, handling requirements, professional roles, and barriers that may affect testing feasibility.
3. Coordinate PMGT in clinical and medicolegal settings by considering laboratory test options, interpretation limitations, billing and coverage, documentation, consent, ethical and legal considerations, and psychosocial needs of families.
4. Discuss a sudden death case that describes the psychosocial impact.
5. Differentiate postmortem genetic testing from other genetic testing contexts.
6. Describe postmortem genetic testing’s clinical utility and workflow for living relatives.
7. Compare the different systems of death investigation across the United States, and describe the difference between a hospital autopsy and a forensic autopsy.
8. Discuss the practical, financial, and educational factors which impact the utilization of postmortem genetic testing in the United States.
9. Recognize the importance, benefits, and goals of molecular genetic testing (MGT) in forensic pathology practice.
10. Recognize the specific postmortem circumstances in which MGT is appropriate.
11. Identify medical disease categories with potential molecular genetic relevance and key components of the investigative approach to each.
12. Recall sample collection, storage, and testing practices, molecular testing techniques and reporting standards, and the most commonly-encountered (fatal) mutations.
13. Identify logistical, sample-related, and practice-based barriers that affect the feasibility of postmortem genetic testing.
14. Recall common sample types collected through medical examiners, coroners, funeral directors and the importance of chain of custody for samples.
15. Identify common limitations for PGMT and how types of genetic testing can differ in PGMT.
16. Evaluate the ethical, legal, and social complexities of postmortem genetic testing for hereditary cardiovascular disease through evolving privacy protections for sensitive familial genetic data under HIPAA and state public record laws.
17. Analyze tension between statutory public health death investigations and the legal hierarchy of family consent.
18. Examine the common emotions and psychological impacts of sudden death and identify strategies for working with families.
19. Describe how PMGT is currently inequitable and should be implemented at the public health level.
20. Identify key components required in clinical documentation for cases involving postmortem genetic testing.
21. Evaluate how different referral pathways influence the required forms and location of documentation in postmortem genetic testing cases.
22. Describe at least three strategies for engaging medicolegal death investigation partners in the development of a postmortem genetic testing program

Genetic Counselor CEUs

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .411 CEUs or 4.11 Category 1 contact hours for the activity, Understanding and Navigating Postmortem Genetic Testing in Genetic Counseling Practice. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion:

1. View recording
2. Pass quiz
3. Complete evaluation